Clinical Trials Browser

Interventional × repotrectinib × 30 days × Clear all

NCT05004116 2026-03-04

A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer

Phase 1/2 Recruiting

Neoplasm Metastasis

NCT06315010 2026-02-25

REPOSE

Phase 2 Recruiting

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung